Action 3218 UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Universal Vision Biotechnology Co., Ltd.

Actions

3218

TW0003218004

Cours en clôture Taipei Exchange
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
256 TWD -0,97 % Graphique intraday de Universal Vision Biotechnology Co., Ltd. +8,47 % -7,58 %
14/03 Universal Vision Biotechnology Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Universal Vision Biotechnology Co. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Health Care Down on Mixed Earnings Prospects - Health Care Roundup
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes
Universal Vision Biotechnology : Clarification of mass media reporting
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer
Universal Vision Biotechnology : The Company is invited to Citi's investor conference call for 1H2022 earnings
Universal Vision Biotechnology : Announcement of 2Q2022 consolidated financial reports approved by the Board of Directors
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company
Universal Vision Biotechnology : Announcement of important resolutions of the Company's 2022 General Shareholders'Meeting
Universal Vision Biotechnology : The Company is invited to Fubon Securities’ 2022Q2 Investment Forum Online
Universal Vision Biotechnology : The Company is invited to Yuanta Securities’ 2022Q2 Investment Forum Online
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 3218
  4. Actualités Universal Vision Biotechnology Co., Ltd.
  5. Autres langues